Araris Biotech raised €2.5M in a funding round in May 2023. The company is based in Zurich, Switzerland. Investors in the round: Innosuisse. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.